Delivery Order SPE2DR25D7059-SPE2DR26F7MSN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension (60ml) with a contract value of $3,047.20 on December 3, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by December 4, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,547.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit dose packaging (10 count) on December 8, 2025, with a completion date of December 9, 2025. This non-compete, firm fixed-price delivery order represents a continuation of pharmaceutical supply under a larger contract vehicle supporting federal medical procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,005.54 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 75mg (10-count units) on November 7, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Oseltamivir Phosphate 45 mg capsules in unit dose packaging of 10 units. This contract represents a firm fixed price delivery order with a ceiling value of $4,604.97 and an ultimate completion date of August 20, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,497.20 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This is a firm fixed price delivery order with no set-aside designation, issued on November 17, 2025, with an ultimate completion date of November 18, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) under a firm fixed-price contract with a ceiling value of $3,121.50. The order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MSNDelivery Order
The Defense Logistics Agency awarded a $1,008.00 delivery order to AmerisourceBergen Drug Corp for oseltamivir 6 mg/ml suspension in 60ml quantities under contract 4570194803. This competitively awarded, firm fixed-price delivery order was issued on December 8, 2025, with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal pharmaceutical procurement needs. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems, the Defense Health Agency, and other government entities. The oseltamivir suspension delivery supports antiviral treatment capabilities across the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/7/25 |